Comparison between Durlax Top Surface IPO and Medicamen Organics IPO.
Durlax Top Surface IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Medicamen Organics IPO is a SME Bookbuilding proposed to list at NSE SME.
| Durlax Top Surface IPO | Medicamen Organics IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Expert Global Consultants Pvt.Ltd. | GYR Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Globalworth Securities Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Durlax Top Surface IPO is up to ₹38.76 Cr whereas the issue size of the Medicamen Organics IPO is up to ₹9.96 Cr. The final issue price of Durlax Top Surface IPO is ₹68.00 per share and of Medicamen Organics IPO is ₹34.00 per share.
| Durlax Top Surface IPO | Medicamen Organics IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹65.00 per share | ₹32.00 per share |
| Issue Price (Upper) | ₹68.00 per share | ₹34.00 per share |
| Issue Price (Final) | ₹68.00 per share | ₹34.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 4000 shares |
| Fresh Issue Size | 39,00,000 shares | 29,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹26.52 Cr | up to ₹9.96 Cr |
| OFS Issue Size | 18,00,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹12.24 Cr | up to ₹0.00 Cr |
| Issue Size Total | 57,00,000 shares | 29,28,000 shares |
| Issue Size Total (Amount) | up to ₹38.76 Cr | up to ₹9.96 Cr |
Durlax Top Surface IPO opens on Jun 19, 2024, while Medicamen Organics IPO opens on Jun 21, 2024. The closing date of Durlax Top Surface IPO and Medicamen Organics IPO is Jun 21, 2024, and Jun 25, 2024, respectively.
| Durlax Top Surface IPO | Medicamen Organics IPO | |
|---|---|---|
| Anchor Bid Date | Jun 18, 2024 | Jun 20, 2024 |
| Issue Open | Jun 19, 2024 | Jun 21, 2024 |
| Issue Close | Jun 21, 2024 | Jun 25, 2024 |
| Basis Of Allotment (Tentative) | Jun 24, 2024 | Jun 26, 2024 |
| Initiation of Refunds (Tentative) | Jun 25, 2024 | Jun 27, 2024 |
| Credit of Share (Tentative) | Jun 25, 2024 | Jun 27, 2024 |
| Listing date (Tentative) | Jun 26, 2024 | Jun 28, 2024 |
| Anchor Lockin End date 1 | Jul 24, 2024 | Jul 26, 2024 |
| Anchor Lockin End date 2 | Sep 22, 2024 | Sep 24, 2024 |
Durlax Top Surface IPO P/E ratio is 16.73, as compared to Medicamen Organics IPO P/E ratio of 30.53.
| Durlax Top Surface IPO | Medicamen Organics IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 95.44 | 81.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 60.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 16.73 | 30.53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹113.07 Cr. | ₹39.78 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 26.20% | 19.90% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 20.20% | 14.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.78 | 0.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.06 | ₹1.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 23.12% | 15.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Durlax Top Surface IPO Retail Individual Investors (RII) are offered 20,00,000 shares while in Medicamen Organics IPO retail investors are offered 20,00,000 shares. Qualified Institutional Buyers (QIB) are offered 22,52,000 shares in Durlax Top Surface IPO and 5,84,000 shares in Medicamen Organics IPO.
| Durlax Top Surface IPO | Medicamen Organics IPO | |
|---|---|---|
| Anchor Investor Reservation | 5,92,000 shares | 8,76,000 shares |
| Market Maker Reservation | 3,00,000 shares | 1,72,000 shares |
| QIB | 22,52,000 shares | 5,84,000 shares |
| NII | 8,56,000 shares | 4,40,000 shares |
| RII | 20,00,000 shares | 10,28,000 shares |
| Employee | ||
| Others | ||
| Total | 57,00,000 shares | 29,28,000 shares |
Durlax Top Surface IPO subscribed 166.79x in total, whereas Medicamen Organics IPO subscribed 993.56x.
| Durlax Top Surface IPO | Medicamen Organics IPO | |
|---|---|---|
| QIB (times) | 48.29x | 173.03x |
| NII (times) | 415.06x | 1,343.83x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 193.95x | 1,309.77x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 166.79x | 993.56x |
